Retinitis Pigmentosa
Overview
Retinitis
pigmentosa (RP) is a rare, hereditary disease that causes the
rod photoreceptors in the
retina to
gradually degenerate. The rods are located in the periphery of
the retina and are responsible for peripheral and night vision.
Cones, another type of photoreceptor, are densely concentrated in
the macula. The cones are responsible for central visual
acuity and color vision.
The disease may be
X-linked (passed from a mother to her son), autosomal recessive
(genes required from both parents) or autosomal dominant (gene
required from one parent) trait. Since it is often a
sex-linked disease, retinitis pigmentosa affects males more than
females.
People with RP usually
first notice difficulty seeing in dim lighting and gradually lose
peripheral vision. The course of RP varies. For some,
the affect on vision may be mild. Others experience a
progression of the disease that leads to blindness.
In many cases, RP is
diagnosed during childhood when the symptoms begin to become
apparent. However, depending on the progression of the
disease, it may not be detected until later in life.
Signs and Symptoms
-
Difficulty seeing
dim lighting
-
Tendency to trip
easily or bump into objects when in poor lighting
-
Gradual loss of
peripheral vision
-
Glare
-
Loss of contrast
sensitivity
-
Eye fatigue (from
straining to see)
Detection and Diagnosis
Retinitis pigmentosa
is usually diagnosed before adulthood. It is often discovered
when the patient complains of difficultly with night vision.
The doctor diagnoses RP by examining the retina with an
ophthalmoscope. The
classic sign of RP is clumps of pigment in the peripheral retinal
called "bone-spicules." A test called electroretinography
(ERG) may also be ordered to study the eye's response to light
stimuli. The test gives the doctor information about the
function of the rods and cones in the retina.
Treatment
There is currently no
standard treatment or therapy for retinitis pigmentosa;
however, scientists have isolated several genes responsible for the
disease. Once RP is discovered, patients and their families
are encouraged to seek genetic counseling.
Current Research
Scientists at Johns
Hopkins University are developing a micro-computer chip prosthesis
called the Multiple-unit Artificial Retina Chipset (MARC).
Once implanted in the retina, the chip transmits images to the brain
that are captured from a small camera mounted on the patient's
glasses. The chip is still in development and is not yet
available for widespread use.
Doctors continue to
search for treatments for RP but have yet to find a cure.
St. Luke's Cataract & Laser
Institute provides this on-line information for educational and
communication purposes only and it should not be construed as
personal medical advice. Information published on this St.
Luke's website is not intended to replace, supplant, or augment a
consultation with an eye care professional regarding the
viewer/user's own medical care. St. Luke's disclaims any and
all liability for injury or other damages that could result from use
of the information obtained from this site. |